WTC Keynote Spotlight #3 - Dr. Borys Todurov

“Transplant Under Stress: Operating in a Warzone”
Monday, August 4, 2025 - 10:45 AM - 11:30 AM PDT

In a time of war, when most flee danger, he runs toward it — with a scalpel in hand and a team behind him. We are deeply honored to welcome Dr. Borys Todurov, one of the most courageous and visionary voices in cardiac surgery, as our Keynote Speaker at WTC 2025.

For over 35 years, Dr. Todurov has been at the forefront of transplant medicine in Ukraine — building institutions, training generations of surgeons, and saving lives. But in recent years, his operating room has been surrounded not only by monitors and instruments — but by air raid sirens and the threat of missiles.

Under extraordinary pressure, Dr. Todurov and his team have continued their mission:

  • Performing over 500 lifesaving operations for wounded soldiers.

  • Carrying out Ukraine’s first pediatric heart transplant and first heart-lung transplant — all while bombs fell around them.

  • Leading evacuations of critical patients under fire, ensuring not only survival, but dignity and care.

In his keynote, “Transplant Under Stress: Operating in a Warzone,” Dr. Todurov will share an unforgettable journey through medicine at the edge —where the human heart is both the organ under his scalpel and the metaphor for a nation refusing to give up.

This is More than a Lecture… It’s a Story of Science, Resilience, and Hope

Do Not Miss This Moment!

Dr. Borys Todurov
  • Professor of Cardiac Surgery and CEO of the Kyiv Heart Institute
  • Honored Medical Doctor of Ukraine and member of the National Academy of Medical Sciences
  • A humanitarian who has performed heart surgery in Iraq, Egypt, Azerbaijan, and more
  • A leader who performed the first heart transplant in Ukraine (2001) and continues to break new ground every year
Registration and Housing Information
Register by May 23, 2025 to secure your spot at WTC 2025 at a discounted rate and guarantee access to the exclusive Keynote with Timothy Caulfield.

Results - TTS By-Election for Councilor-at-large - Europe (2025-2026)

Marti Manyalich Vidal

Spain
Biography

Marti Manyalich Vidal, Spain

Dr. Marti Manyalich, MD, PhD, is a globally recognized specialist with decades of experience in the field of organ, tissue and cell donation for transplantation. In 1991 he founded  the Transplant Procurement Management (TPM) program dedicated to empowering health professionals in donation and transplantation worldwide and President of the DTI Foundation (Donation & Transplantation Institute) a non-profit organization based in Barcelona with the aim to raise organ donation in the world to improve society’s quality of life by training health professionals in organ donation & transplantation, trough cooperation projects and consultancy.  

Dr Marti Manyalich is also former Assessor on Transplantation at the Hospital Clinic de Barcelona, as well as professor of international Master in donation & Transplantation of organ tissues and cells at University of Barcelona. He has written many scientific publications and holds memberships in the most relevant international organizations in this field. As an example, he has been president of ISODP & ETCO, vice president of EATB and TTS European Councillor, honorary member of ESOT, among other positions and recognitions for his outstanding career."

We are pleased to announce that Dr. Martí Manyalich Vidal (Spain) has been elected as the new Councilor-at-Large for Europe following the recent by-election held in accordance with our bylaws. He will serve the remainder of the current term through September 23, 2026, succeeding Dr. John Forsythe.

Dr. Manyalich is a globally recognized expert in organ, tissue, and cell donation and transplantation. He is the founder of the Transplant Procurement Management (TPM) program and President of the Donation & Transplantation Institute (DTI Foundation). His distinguished career includes leadership roles across numerous international organizations and contributions to global education and policy in the field.

We thank all candidates and members who participated in this important election.


ISN-TTS Sister Centers Announcement

The ISN and The Transplantation Society are pleased to announce five newly formed partnerships that have been accepted into the joint ISN-TTS Sister Transplant Centers (STC) Program in 2025.


Developing kidney transplant programs worldwide: New, upgraded and graduated partnerships through ISN-TTS Sister Transplant Centers

The grant program is a joint initiative between the ISN and TTS to help establish new kidney transplant centers and develop existing kidney transplant programs in emerging countries.

The ISN and TTS warmly congratulate the upgraded and graduated centers on all they have accomplished and wish the newly formed partnerships every success as they advance through the program.

STC Philippines-Philippines-Spain (trio partnership)

Cotabato Regional Medical Center, Southern Philippines Medical Center (SPMC), and Hospital Clínic (HC), University of Barcelona. The SPMC and HC graduated as an ISN-TTS STC pair in 2023.

STC Nigeria-Canada

Adult and Paediatric Nephrology Unit, University College Hospital Ibadan and Nephrology Section, Alberta Children's Hospital

STC Peru-USA

Unidad de Trasplante Renal, Hospital Nacional Edgardo Rebagliati Martins and Yale Health

STC Zambia-USA

University Teaching Hospital of Lusaka and Stanford University

STC Zambia-Spain

Ndola Teaching Hospital and University Hospital of A Coruña

Technology in Medicine Spotlight - World’s smallest pacemaker is activated by light

Northwestern University engineers have developed a pacemaker so tiny that it can fit inside the tip of a syringe — and be non-invasively injected into the body.
Although it can work with hearts of all sizes, the pacemaker is particularly well-suited to the tiny, fragile hearts of newborn babies with congenital heart defects. Smaller than a single grain of rice, the pacemaker is paired with a small, soft, flexible, wireless, wearable device that mounts onto a patient’s chest to control pacing. When the wearable device detects an irregular heartbeat, it automatically shines a light pulse to activate the pacemaker. These short pulses— which penetrate through the patient’s skin, breastbone and muscles — control the pacing. Designed for patients who only need temporary pacing, the pacemaker simply dissolves after it’s no longer needed. All the pacemaker’s components are biocompatible, so they naturally dissolve into the body’s biofluids, bypassing the need for surgical extraction

Transplantation Journal Highlights

Transplantation Journal - Social Media Content

Obesity-associated Inflammation and Alloimmunity
Obesity is a worldwide health problem with a rapidly rising incidence. In organ transplantation, increasing numbers of patients with obesity accumulate on waiting lists and undergo surgery. Obesity is in general conceptualized as a chronic inflammatory disease, potentially impacting alloimmune response and graft function.
The Microscope and Beyond: Current Trends in the Characterization of Kidney Allograft Rejection From Tissue Samples
The Banff classification is regularly updated to integrate recent advances in the characterization of kidney allograft rejection, gathering novel diagnostic, prognostic, and theragnostic data into a diagnostic and pathogenesis-based framework. Despite ongoing research on noninvasive biomarkers of kidney rejection, the Banff classification remains, to date, biopsy-centered, primarily relying on a semiquantitative histological scoring system that overall lacks reproducibility and granularity.

Transplantation Direct - Social Media Content

Comprehensive Phenotyping and Cytokine Production of Circulating B Cells Associate Resting Memory B Cells With Early Antibody-mediated Rejection in Kidney Transplant Recipients
B cells play a crucial role in kidney transplantation through antibody production and cytokine secretion. To better understand their impact on kidney transplantation, this retrospective study aimed to characterize circulating B-cell phenotypes and cytokine production in a cohort of kidney transplant patients to identify whether pretransplant donor-specific antibodies (DSAs) or biopsy-proven rejection is associated with different B-cell profiles.
Outcomes for Early Liver Transplantation for Alcohol-associated Liver Disease in High-acuity Liver Transplant Recipients With Alcohol Use Disorder
Alcohol use disorder (AUD) incidence is increasing, and alcohol-associated liver disease is the leading indication for liver transplantation (LT) in the United States. Many centers have adopted “early LT” (ELT) for patients with <6 mo of abstinence. This study evaluates whether ELT outcomes in acutely ill recipients are equivalent to standard LT (SLT).

Research Grants and Fellowship Programs

TTS provides funding to individual investigators to support their research in transplantation. The spectrum of studies includes basic, clinical/epidemiological and translational. This individual should have spent five years or less performing research in transplantation (and/or immunology relating to transplant) since obtaining their last doctoral degree (PhD, MD, PharmD, or equivalent). One of these research grants will be preferentially designated to TTS members from a low- or middle-income country. Please send application materials and any questions to jennifer.groverman@tts.org.

Letter of Intent Deadline: April 30, 2025

The ISN and TTS join forces to support the training of young physicians from low resource areas receiving hands-on training in advanced host institutions to acquire state of-the-art knowledge in transplantation. The ultimate goal of such training is to improve the transplantation standards in their home countries upon their return and become leaders in their fields. The training focuses on providing the skills and knowledge specifically required by the home institution. ISN-TTS Fellowship trainings can be long (6-12 months) or short term (3-6 months).

Application Deadline: May 1, 2025

This grant will provide funding of up to $20,000 USD per grant to support research focused on sex and gender equity, advocacy, and health in solid organ transplantation amongst Indigenous peoples globally. This may include basic, clinical, or translational research. The recipient must be a clinician, health policy administrator, social scientist, clinical and/or basic science researcher in solid organ transplantation or donation, and/or Indigenous health relating to solid organ transplant.

Application Deadline: May 1, 2025


IXA 2025 Call for Abstracts and Awards Deadlines

Call for Abstracts Deadline: May 1, 2025
VIEW Abstract Topics
Congress Awards Application Deadline: May 26, 2025

TID Best Practices Surveys

The TID section invites you to participate in the following 3 surveys.

These surveys aims to assist in mapping best practices in different scenarios and across different regions with the goal of sharing learnings with the global transplant community to guide practice and optimize patient outcomes.

In the News


Social

Contact

Staff Directory
+1-514-874-1717
info@tts.org

Address

The Transplantation Society
International Headquarters
740 Notre-Dame Ouest
Suite 1245
Montréal, QC, H3C 3X6
Canada